Bas van de Waterbeemd

Improved OMV vaccine against Neisseria meningitidis using genetically engineered strains and a detergent-free purification process

Bas van de Waterbeemd, Mathieu Streefland, Peter van der Ley et al. · Vaccine · 2010 · 184 citations

Vaccination, Reverse Vaccinology, Vaccine Research +10

Cysteine Depletion Causes Oxidative Stress and Triggers Outer Membrane Vesicle Release by Neisseria meningitidis; Implications for Vaccine Development

Bas van de Waterbeemd, G. Zomer, Jan van den IJssel et al. · PLoS ONE · 2013 · 89 citations · Full text

Microbial Pathogens, Immunology, Innate Immunity +20

Genome-Wide Gene Expression Analysis of Bordetella pertussis Isolates Associated with a Resurgence in Pertussis: Elucidation of Factors Involved in the Increased Fitness of Epidemic Strains

Audrey J. King, Saskia van der Lee, Archena Mohangoo et al. · PLoS ONE · 2013 · 76 citations · Full text

Epidemic Strains, Microbial Pathogens, Genetics +19

Improved Production Process for Native Outer Membrane Vesicle Vaccine against Neisseria meningitidis

Bas van de Waterbeemd, G. Zomer, Patricia Kaaijk et al. · PLoS ONE · 2013 · 68 citations · Full text

Vaccination, Mucosal Vaccination, Vaccine Development +14

Quantitative Proteomics Reveals Distinct Differences in the Protein Content of Outer Membrane Vesicle Vaccines

Bas van de Waterbeemd, Geert P. M. Mommen, Jeroen L. A. Pennings et al. · Journal of Proteome Research · 2013 · 66 citations

Vaccination, Protein Content, Proteomic Technology +15